Netflix, Intuitive, Zoom Price Targets, October 21 2026

Netflix

Netflix is a streaming company that earns most of its money from monthly subscriptions, sold in more than 190 countries. It launched a cheaper plan with ads in late 2022. Its own productions include series such as Stranger Things and Squid Game, along with a growing slate of live events. Third-quarter revenue came to $12.87 billion, 11.8% more than a year earlier. Earnings came to $0.87 a share, against a $0.82 consensus.

Netflix guided fourth-quarter earnings to $0.67 a share, below a $0.73 consensus. It put fourth-quarter net income at $2.79 billion, against $3.07 billion expected. It also cut its 2026 ad revenue forecast to about $2.7 billion from about $3 billion. Ted Sarandos, who runs the company with co-CEO Greg Peters, told analysts “we could do better.” Days earlier, Netflix had announced layoffs affecting about 6% of its staff.

Most Desks Trim Their Netflix Targets

Laurent Yoon of Bernstein cut his target from $95 to $80 today, a Wednesday. Mark Mahaney of Evercore ISI went from $110 to $90. Jessica Reif Ehrlich of BofA kept Buy and lowered hers from $105 to $90. Maria Ripps of Canaccord kept Buy and moved from $125 to $110.

Doug Anmuth of JPMorgan kept Overweight and trimmed his target from $85 to $81. Jason Helfstein of Oppenheimer kept Outperform and cut from $85 to $80. Sean Diffley of Morgan Stanley kept Overweight and lowered his target from $80 to $77. Barton Crockett of Rosenblatt cut his from $75 to $71. Kannan Venkateshwar of Barclays kept Equal-Weight and moved from $70 to $65.

Laura Martin of Needham downgraded the stock to Hold from Buy. Justin Patterson of KeyBanc reiterated Overweight with an $85 target. Ralph Schackart of William Blair reiterated Outperform. Andrew Marok of Raymond James reiterated Market Perform. Matthew Condon of Citizens reiterated Market Perform too.

More notes came later on Wednesday. Michael Morris of Guggenheim kept Buy and cut his target from $80 to $78. John Hodulik of UBS kept Buy and moved from $115 to $100. Jason Bazinet of Citi went from $100 to $85. Thomas Champion of Piper Sandler kept Overweight and lowered his from $85 to $78. Alicia Reese of Wedbush cut hers from $90 to $80. John Blackledge of TD Cowen reiterated Buy at $100.

Netflix’s Record on AnaChart

Netflix draws 34 covering analysts on AnaChart. Their average target is $104.41, with a high of $135 and a low of $57. Ratings split 74.17% Buy and 25.83% Hold. AnaChart’s tracking shows 81.83% of Netflix targets get met, after about 190 days on average. Crockett has met 39 of his 55 targets on the stock, with an average potential upside of 6.34%. Venkateshwar has met 20 of 29, with an average potential upside of 0.43%.

Intuitive Surgical

Intuitive Surgical makes the da Vinci robotic surgery system and is based in Sunnyvale, California. Surgeons use the system in general surgery, urology and gynecology, among other fields. Its newest multiport model is the da Vinci 5. Its Ion platform handles robotic lung biopsies. Much of its revenue repeats, from instruments, accessories and service tied to each installed system. Third-quarter revenue reached $3.05 billion, above the $2.91 billion estimate.

The company reported after Tuesday’s close. Earnings came to $3.00 a share, against a $2.65 consensus. A year earlier it earned $2.40 a share on $2.51 billion.

An Upgrade and Split Target Moves on Intuitive

Hans Engel of Erste Group upgraded Intuitive Surgical to Buy from Hold today, a Wednesday. David Rescott of Baird kept Outperform and raised his target from $513 to $550. Jayson Bedford of Raymond James trimmed his from $483 to $480. Anthony Petrone of Mizuho lowered his from $415 to $400.

Suraj Kalia of Oppenheimer reiterated Outperform with a $500 target. Ryan Zimmerman of BTIG reiterated Buy at $454.

Later in the day, Christopher Pasquale of Barclays kept Overweight and raised his target from $485 to $500. Mike Kratky of Leerink Partners went from $473 to $503. Robbie Marcus of JPMorgan lifted his from $450 to $475. Kendall Au of RBC Capital cut his from $575 to $550. Vijay Kumar of Evercore ISI lowered his from $400 to $385, with an In-Line rating. Larry Biegelsen of Wells Fargo trimmed his from $487 to $486. Mathew Blackman of TD Cowen reiterated Buy at $485.

Intuitive Surgical’s Record on AnaChart

Intuitive Surgical draws 26 covering analysts on AnaChart. Their average target is $551.07. The high is $931 and the low is $366. Ratings split 72.73% Buy, 25.97% Hold and 1.3% Sell. AnaChart’s tracking shows 75.32% of its targets get met, after about 147 days on average. Zimmerman has met 30 of his 39 targets on the stock, with an average potential upside of 7.09%.

Zoom

Zoom Communications sells video meetings, phone, chat and contact center software, mostly by subscription. The company is based in San Jose, California. Its product lines include Zoom Workplace, Zoom Phone and Zoom Contact Center. Revenue for its fiscal second quarter came to $1.28 billion, just above the $1.27 billion estimate. Earnings were $1.55 a share, against $1.48.

At its Zoomtopia customer conference on Tuesday, Zoom introduced a Unified Context Layer and several new AI products. Its next report is due November 23. The consensus for that quarter sits at $1.49 a share on $1.28 billion in revenue.

Oppenheimer Upgrades Zoom After Zoomtopia

Ittai Kidron of Oppenheimer upgraded Zoom to Outperform from Perform today, a Wednesday, with a $130 target. Siti Panigrahi of Mizuho reiterated Outperform at $120. Allan Verkhovski of BTIG reiterated Buy with a $125 target. Thomas Blakey of Cantor Fitzgerald reiterated Neutral at $104. Patrick Walravens of Citizens reiterated Market Perform. Rishi Jaluria of RBC Capital reiterated Outperform at $130. Taylor McGinnis of UBS kept Neutral and cut the UBS target from $115 to $112.

Zoom’s Record on AnaChart

Zoom draws 19 covering analysts on AnaChart. Their average target is $110.24, with a high of $133 and a low of $10. Ratings split 60.34% Buy, 34.48% Hold and 5.17% Sell. AnaChart’s tracking shows 73.03% of Zoom targets get met, after about 195 days on average. Meta Marshall of Morgan Stanley has met 34 of her 43 targets on the stock, with an average potential upside of 14.04%.

What the Performance Matrix Shows

Netflix has the best met ratio of the three, and Zoom the lowest. An Intuitive Surgical target that gets met lands in about 147 days. AnaChart’s first Intuitive Surgical forecast dates to October 2012.

AnaChart tracks every price target against what happened to the stock afterward, desk by desk and analyst by analyst. The ticker pages linked above break out each record by analyst, firm and year. AnaChart’s full data set holds more than 760,000 analyst calls on more than 9,000 tickers, active and delisted. More than 680,000 carry a price target and more than 730,000 carry a rating. It is the second largest database of its kind. The raw file is available through the AnaChart store.

The previous update covered EyePoint, Zions and GE Aerospace on October 20.

Top analyst price target moves on AnaChart, October 21 2026
Top analyst price target moves on AnaChart.com, October 21 2026